AdvisorShares Psychedelics ETF (PSIL)
NYSEARCA: PSIL · Real-Time Price · USD
20.28
+0.41 (2.06%)
May 21, 2026, 12:29 PM EDT - Market open
PSIL Holdings Information
PSIL is an equity ETF with a total of 32 individual holdings. The top holdings are COMPASS Pathways stock at 10.92%, AtaiBeckley at 9.88%, Relmada Therapeutics at 8.57%, Definium Therapeutics at 8.04%, and GH Research at 6.30%.
Total Holdings
32
Top 10 Percentage
67.78%
Asset Class
Equity
ETF Category
Miscellaneous Sector
Assets
33.65M
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | CMPS | COMPASS Pathways plc | 10.92% |
| 2 | ATAI | AtaiBeckley Inc. | 9.88% |
| 3 | RLMD | Relmada Therapeutics, Inc. | 8.57% |
| 4 | DFTX | Definium Therapeutics, Inc. | 8.04% |
| 5 | GHRS | GH Research PLC | 6.30% |
| 6 | NRXP | NRx Pharmaceuticals, Inc. | 5.87% |
| 7 | NBIX | Neurocrine Biosciences, Inc. | 5.21% |
| 8 | ALKS | Alkermes plc | 4.49% |
| 9 | CSE: DRUG | Bright Minds Biosciences Inc. | 4.43% |
| 10 | ABBV | AbbVie Inc. | 4.09% |
| 11 | ANRO | Alto Neuroscience, Inc. | 3.96% |
| 12 | CSE: QNTM | Quantum BioPharma Ltd. | 3.96% |
| 13 | JNJ | Johnson & Johnson | 3.77% |
| 14 | NEO: HELP | Cybin Inc. | 3.73% |
| 15 | SUPN | Supernus Pharmaceuticals, Inc. | 3.66% |
| 16 | NEUP | Neuphoria Therapeutics Inc. | 3.35% |
| 17 | STIM | Neuronetics, Inc. | 2.36% |
| 18 | KTTA | Pasithea Therapeutics Corp. | 1.72% |
| 19 | PBM | Psyence Biomedical Ltd. | 1.19% |
| 20 | SILO | Silo Pharma, Inc. | 1.17% |
| 21 | VTGN | Vistagen Therapeutics, Inc. | 0.77% |
| 22 | n/a | Blackrock Treasury Trust Instl 62 | 0.77% |
| 23 | TSX: NUMI | Numinus Wellness Inc. | 0.72% |
| 24 | IGC | IGC Pharma, Inc. | 0.48% |
| 25 | IXHL | Incannex Healthcare Inc. | 0.40% |
As of May 18, 2026